Strategic partnerships The Jackson Laboratory is actively expanding collaborations with major institutions (Broad Institute, Boston Children’s Hospital) to develop genetic medicines and establish repeatable therapeutic practices, presenting a clear opportunity to position complementary research services, training programs, or data collaboration offerings.

Genomics education JAX hosts comprehensive education across career stages and clinical genetics integration, indicating demand for scalable training solutions, continuing education credits, and partner-led curricula that could be offered as certified programs or on-site workshops.

Therapeutic genetics Recent announcements around the Center for Therapeutic Genetics and partnerships suggest a strong focus on rare and ultra-rare disease therapies, creating sales opportunities for bespoke preclinical models, referential data services, and translational support platforms.

Research infrastructure With over 13,000 genetically specialized mouse strains and the Mouse Genome Informatics database, JAX represents a potential customer for advanced biotech tools, data analytics, bioinformatics services, and software that enhances model management and data interoperability.

Global reach Operating 11 locations and multiple international collaborations alongside remote partnerships, JAX is positioned to engage in multinational program development, cross-border consortia, and scalable enterprise solutions that support global research initiatives and compliance requirements.